[HTML][HTML] Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of …

PV Nazarov, AK Wienecke-Baldacchino… - BMC medical …, 2019 - Springer
Background The amount of publicly available cancer-related “omics” data is constantly
growing and can potentially be used to gain insights into the tumour biology of new cancer …

[HTML][HTML] Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: predict before protect

X Zhang, Z Tai, F Miao, H Huang, Q Zhu, L Bao… - Frontiers in …, 2022 - frontiersin.org
Malignant melanoma is widely acknowledged as the most lethal skin malignancy. The
metabolic reprogramming in melanoma leads to alterations in glycolysis and oxidative …

[HTML][HTML] Metabolic molecule PLA2G2D is a potential prognostic biomarker correlating with immune cell infiltration and the expression of immune checkpoint genes in …

H Liu, R Xu, C Gao, T Zhu, L Liu, Y Yang… - Frontiers in …, 2021 - frontiersin.org
Cervical squamous cell carcinoma (CSCC) is the major pathological type of cervical cancer
(CC), the second most prevalent reproductive system malignant tumor threatening the health …

[HTML][HTML] Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with …

Q Li, J Li, T Wen, W Zeng, C Peng, S Yan, J Tan… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Although laboratory studies have implicated the high mobility group box 1 (HMGB1) in
melanoma, its clinical relevance remains unclear. We analyzed nearly 100 cases of human …

[HTML][HTML] Progression of melanoma is suppressed by targeting all transforming growth factor‑β isoforms with an Fc chimeric receptor

S Kodama, KΑ Podyma‑Inoue… - Oncology …, 2021 - spandidos-publications.com
Melanoma is an aggressive type of cancer originating from the skin that arises from
neoplastic changes in melanocytes. Transforming growth factor‑β (TGF‑β) is a pleiotropic …

[HTML][HTML] The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma

C Huynh, L Poliseno, MF Segura, R Medicherla… - PloS one, 2011 - journals.plos.org
Several reports have demonstrated a role for aberrant NOTCH signaling in melanoma
genesis and progression, prompting us to explore if targeting this pathway is a valid …

Tumor microenvironment and lymphocyte infiltration

G Rahir, M Moser - Cancer Immunology, Immunotherapy, 2012 - Springer
There is ample evidence that the presence of tumor-infiltrating T lymphocytes is associated
with a favorable prognostic in patients. These observations suggest that a limiting step to …

Emerging biomarkers in cutaneous melanoma

A Eisenstein, EC Gonzalez, R Raghunathan… - Molecular Diagnosis & …, 2018 - Springer
Earlier identification of aggressive melanoma remains a goal in the field of melanoma
research. With new targeted and immune therapies that have revolutionized the care of …

The “-OMICS” facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers

D Donnelly III, PP Aung, G Jour - Seminars in cancer biology, 2019 - Elsevier
In the recent decade, cutting edge molecular and proteomic analysis platforms
revolutionized biomarkers discovery in cancers. Melanoma is the prototype with over 51,100 …

High NUSAP1 expression predicts poor prognosis in colon cancer

Z Liu, C Guan, C Lu, Y Liu, R Ni, M Xiao… - Pathology-Research and …, 2018 - Elsevier
Background and aim Nucleolar and spindle-associated protein 1 (NUSAP1) is an
indispensable mitotic regulator. Aberrant NUSAP1 expression is associated with perturbed …